CrossRef Insulin-like growth factor binding proteins in metabolic dysfunction-associated steatotic liver disease Kuo Fang, Ji Miao, Guobin Song Frontiers in Endocrinology .2026;[Epub] CrossRef Edible extracellular vesicle-like particles from Exocarpium Citri Grandis: A natural nanoplatform for oral treatment of metabolic dysfunction-associated steatotic liver disease Jingxiu Zhao, Tao Huang, Chengshi Fu, Yingjie Xiong, Anran Gao, Kui Wang, Yujia Song, Zanxiang Luo, Xiangyun Teng, Wei Zhao, Jianhua Xu International Journal of Biological Macromolecules .2026
Escalating symptoms despite standard management may require protocol modification
Most programs run at least 12 to 24 weeks before meaningful results assessment, though many patients continue for a year or longer
This is another blind spot in the online era